Let’s journey back to 1978 when Kiran Mazumdar Shaw founded Biocon in Bangalore. What began as a humble enzyme manufacturing company has evolved into a global biopharmaceutical powerhouse.
Under the leadership of Shaw, fondly known as the ‘Bioqueen of India,’ Biocon’s journey has been nothing short of extraordinary.
Biocon swiftly emerged as a trailblazer, pioneering advancements in bio-manufacturing and research.
Milestones:
- The year 2000 marked a significant milestone with Biocon becoming the first Indian company to receive U.S. approval for its breakthrough drug, recombinant human insulin.
- The approval of Semglee, the biosimilar insulin glargine co-developed with Mylan, for the U.S. market in 2021 marked a triumph in navigating regulatory landscapes.
Since then, it’s not just been about laboratories and research; it’s been about rewriting the script of healthcare in India.
Numbers echo the success story – with a presence in over 120 countries and a research and development centre in Bangalore, Biocon isn’t just a biotech company; it’s a beacon of health innovation.
The strategic partnership with Mylan in 2009 further catapulted Biocon into the league of global biopharma players.
Today, as we walk past Biocon’s state-of-the-art facilities or hear about the latest advancements in biopharmaceuticals, it’s not just about drug manufacturing; it’s about fostering hope and healing.
Biocon Share Price History
Year | Share Price | Gain / Loss |
---|---|---|
IPO | ₹ 26.25 | |
Listing | ₹ 53.40 | + 103.4% |
2004 | ₹ 42.35 | - 20.7% |
2005 | ₹ 41.15 | - 2.8% |
2006 | ₹ 31.10 | - 24.4% |
2007 | ₹ 48.30 | + 55.3% |
2008 | ₹ 19.40 | - 59.8% |
2009 | ₹ 46.05 | + 137.4% |
2010 | ₹ 70.20 | + 52.4% |
2011 | ₹ 45.60 | - 35.0% |
2012 | ₹ 47.70 | + 4.6% |
2013 | ₹ 77.00 | + 61.4% |
2014 | ₹ 70.90 | - 7.9% |
2015 | ₹ 86.35 | + 21.8% |
2016 | ₹ 158.50 | + 83.6% |
2017 | ₹ 268.60 | + 69.5% |
2018 | ₹ 314.40 | + 17.1% |
2019 | ₹ 293.90 | - 6.5% |
2020 | ₹ 465.30 | + 58.3% |
2021 | ₹ 363.60 | - 21.9% |
2022 | ₹ 261.80 | - 28.0% |
2023 | ₹ 249.60 | - 4.7% |
2024 | ₹ 315.85 | + 26.5% |
Biocon Share Price Chart
Click here for high resolution Biocon Share Price chartBiocon Share Returns Calculator
Enter any amount in the 'Investment amount' field and select a year.
The Biocon calculator will tell you the value of your Biocon investment in 2024.
Invested Amount
Investment Year
- During 2004, the share price of Biocon was ₹ 26.25.
- If you had bought shares worth ₹ 2500 in 2004, you would have 952 shares today.
- At the end of 2024, the current value of your shares would be ₹ 300810.
Biocon Share Returns Comparison
Invested Amount
Investment Year
Other Investment
Interest Rate